Sudden cardiac death: a modern pathology approach to hypertrophic cardiomyopathy

Linda Kocovski1, John Fernandes

  • 1From the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Kocovski); and the Regional Forensic Pathology Unit, Hamilton General Hospital, Hamilton, Ontario, Canada (Dr Fernandes).

Insights

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young people, often presenting without warning. Genetic testing is crucial for family members to assess and mitigate risks associated with HCM.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in adolescents and young adults.
  • Sudden cardiac death during exertion, such as sports, can be the initial presentation of HCM.
  • Clinical symptoms include exertional dyspnea, angina, and syncope.

Purpose of the Study:

  • To highlight the pathological findings of hypertrophic cardiomyopathy.
  • To emphasize the importance of molecular analysis for genetic counseling.
  • To inform about risk assessment and reduction strategies for sudden cardiac death in families.

Main Methods:

  • Postmortem examination revealing asymmetrical septal thickening and left ventricular outflow tract mural plaque.
  • Histologic analysis demonstrating cardiac myocyte hypertrophy, myofiber disarray, and fibrosis.
  • Molecular analysis to identify known genetic abnormalities.

Main Results:

  • Pathological hallmarks include specific cardiac structural changes and fibrosis.
  • Genetic abnormalities are identifiable through molecular analysis.
  • Identification of genetic causes facilitates risk stratification.

Conclusions:

  • Hypertrophic cardiomyopathy presents significant risks, including sudden cardiac death, particularly in young individuals.
  • Understanding the genetic basis of HCM is vital for effective genetic counseling.
  • Early identification and risk assessment through molecular analysis can help reduce sudden cardiac death in affected families.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
869
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
622